These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9780151)

  • 21. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
    Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tandemly repeated Fc domain augments binding avidities of antibodies for Fcgamma receptors, resulting in enhanced antibody-dependent cellular cytotoxicity.
    Nagashima H; Tezuka T; Tsuchida W; Maeda H; Kohroki J; Masuho Y
    Mol Immunol; 2008 May; 45(10):2752-63. PubMed ID: 18353438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Sondermann P; Huber R; Oosthuizen V; Jacob U
    Nature; 2000 Jul; 406(6793):267-73. PubMed ID: 10917521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
    Imai M; Ohta R; Varela JC; Song H; Tomlinson S
    Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of ligand-binding activity of isolated murine Fc gamma receptor.
    Schneider RJ; Atkinson JP; Krause V; Kulczycki A
    J Immunol; 1981 Feb; 126(2):735-40. PubMed ID: 7451992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.
    Scallon BJ; Tam SH; McCarthy SG; Cai AN; Raju TS
    Mol Immunol; 2007 Mar; 44(7):1524-34. PubMed ID: 17045339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
    White DM; Jensen MA; Shi X; Qu Zx ; Arnason BG
    Protein Expr Purif; 2001 Apr; 21(3):446-55. PubMed ID: 11281720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of the soluble, truncated form of an Fc receptor (mouse Fc gamma RII) to membrane-bound IgG as measured by total internal reflection fluorescence microscopy.
    Gesty-Palmer D; Thompson NL
    J Mol Recognit; 1997; 10(2):63-72. PubMed ID: 9376129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions.
    Baudino L; Shinohara Y; Nimmerjahn F; Furukawa J; Nakata M; Martínez-Soria E; Petry F; Ravetch JV; Nishimura S; Izui S
    J Immunol; 2008 Nov; 181(9):6664-9. PubMed ID: 18941257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa.
    Maxwell KF; Powell MS; Hulett MD; Barton PA; McKenzie IF; Garrett TP; Hogarth PM
    Nat Struct Biol; 1999 May; 6(5):437-42. PubMed ID: 10331870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of the murine unglycosylated IgG1 Fc fragment.
    Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
    J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural difference in the complement activation site of human IgG1 and IgG3.
    Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
    Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.
    Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
    J Immunol Methods; 2005 Nov; 306(1-2):93-103. PubMed ID: 16236307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies.
    Nechansky A; Schuster M; Jost W; Siegl P; Wiederkum S; Gorr G; Kircheis R
    Mol Immunol; 2007 Mar; 44(7):1815-7. PubMed ID: 17011625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effector functions of immunoglobulins: implications for therapy.
    Ward ES; Ghetie V
    Ther Immunol; 1995 Apr; 2(2):77-94. PubMed ID: 8729879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
    Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
    J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering therapeutic monoclonal antibodies.
    Liu XY; Pop LM; Vitetta ES
    Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
    Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
    Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates.
    Datta-Mannan A; Witcher DR; Tang Y; Watkins J; Jiang W; Wroblewski VJ
    Drug Metab Dispos; 2007 Jan; 35(1):86-94. PubMed ID: 17050651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.